Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease
Status:
Terminated
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
Patients with Parkinson's disease represent a significant proportion of VA elderly patients.
Sleep disturbances and caregiver burnout association with this condition represent a
significant problem. In this study, the investigators propose to perform an evaluation of a
fixed doe of ramelteon on sleep in VA outpatients diagnosed with Parkinson's disease.
The hypothesis to be examined is that ramelteon will improve the quality of sleep in patients
with Parkinson's disease while indirectly improving the quality of life for the patients and
caregivers. The investigators further hypothesize that these changes will occur through
restructuring and normalization of the sleep architecture.
Phase:
Phase 4
Details
Lead Sponsor:
Southern California Institute for Research and Education